Compare · EW vs XPEL
EW vs XPEL
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and XPEL Inc. (XPEL): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while XPEL operates in Industrials - the two are in different parts of the market.
- EW is the larger of the two at $49.43B, about 40.0x XPEL ($1.24B).
- Over the past year, EW is up 12.5% and XPEL is up 19.5% - XPEL leads by 7.1 points.
- EW has been more active in the news (7 items in the past 4 weeks vs 2 for XPEL).
- EW has more recent analyst coverage (25 ratings vs 3 for XPEL).
- Company
- Edwards Lifesciences Corporation
- XPEL Inc.
- Price
- $85.84-0.14%
- $44.98+1.12%
- Market cap
- $49.43B
- $1.24B
- 1M return
- +3.72%
- +2.34%
- 1Y return
- +12.46%
- +19.53%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 7
- 2
- Recent ratings
- 25
- 3
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
XPEL Inc.
XPEL, Inc. manufactures, sells, distributes, and installs after-market automotive products in the United States, China, Canada, Continental Europe, the United Kingdom, Asia Pacific, Latin America, the Middle East/Africa, and internationally. The company offers automotive surface and paint protection, headlight protection, and automotive and architectural window films, as well as proprietary software. It also provides merchandise and apparel, and ceramic coatings. In addition, the company offers paint protection kits, car wash products, after-care products, and installation tools through its website. It sells its products to independent installers and new car dealerships, third party distributors, owned installation centers, and franchisees and online. The company was founded in 1997 and is headquartered in San Antonio, Texas.
Latest EW
- SEC Form 3 filed by new insider Mistras Theodora
- SVP, Corporate Controller Dahl Andrew M. sold $48,853 worth of shares (568 units at $86.08), decreasing direct ownership by 4% to 15,334 units (SEC Form 4)
- CVP,Strategy/Corp Development Bobo Donald E Jr sold $2,000,193 worth of shares (23,145 units at $86.42) (SEC Form 4)
- SEC Form SD filed by Edwards Lifesciences Corporation
- CVP, TMTT & Surgical Chopra Daveen sold $126,905 worth of shares (1,500 units at $84.60), decreasing direct ownership by 3% to 44,324 units (SEC Form 4)
- CVP, TAVR Lippis Daniel J. exercised 620 shares at a strike of $72.68 and sold $50,307 worth of shares (620 units at $81.14) as part of a pre-agreed trading plan (SEC Form 4)
- CVP,Strategy/Corp Development Bobo Donald E Jr sold $1,472,678 worth of shares (17,968 units at $81.96), decreasing direct ownership by 30% to 22,798 units (SEC Form 4)
- CEO Zovighian Bernard J converted options into 47,207 shares, covered exercise/tax liability with 26,198 shares, gifted 26,640 shares, received a gift of 26,640 shares and sold $2,833,013 worth of shares (36,351 units at $77.93) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 99,165 units (SEC Form 4)
- CVP,Strategy/Corp Development Bobo Donald E Jr converted options into 13,457 shares and covered exercise/tax liability with 7,469 shares, increasing direct ownership by 22% to 32,766 units (SEC Form 4)
- CVP, TMTT & Surgical Chopra Daveen converted options into 13,583 shares and covered exercise/tax liability with 7,538 shares, increasing direct ownership by 15% to 45,824 units (SEC Form 4)
Latest XPEL
- XPEL Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits
- XPEL Announces Approximately $110 Million Manufacturing and Supply Chain Investment, Including Expansion of San Antonio Operations and Acquisition of Manufacturing Facility in China
- Amendment: SEC Form SCHEDULE 13G/A filed by XPEL Inc.
- XPEL Marks Skin Cancer Awareness Month and National Don't Fry Day with Limited-Time Window Tint Offer to Help Drivers Beat Heat and UV Exposure
- SEC Form 10-Q filed by XPEL Inc.
- XPEL Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- XPEL Reports Revenue Growth of 13.1% to $117.4 million, EBITDA Growth of 17.8% to $17.0 million in First Quarter 2026
- SEC Form 3 filed by new insider Thornton Mark Andrew
- SEC Form DEFA14A filed by XPEL Inc.
- SEC Form DEF 14A filed by XPEL Inc.